Skip to Main Content

Paper Details

Risks to the 340B Drug Pricing Program-Reply.
JAMA
0
2022
Author NameAffiliation
Ameet SarpatwariDivision of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School
  • 1 - 1

Datasets

Release 1.2